These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 30642906
1. Human Intestinal Enteroids as a Model System of Shigella Pathogenesis. Koestler BJ, Ward CM, Fisher CR, Rajan A, Maresso AW, Payne SM. Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642906 [Abstract] [Full Text] [Related]
2. Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model. Ranganathan S, Doucet M, Grassel CL, Delaine-Elias B, Zachos NC, Barry EM. Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642900 [Abstract] [Full Text] [Related]
5. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium. D'Hauteville H, Khan S, Maskell DJ, Kussak A, Weintraub A, Mathison J, Ulevitch RJ, Wuscher N, Parsot C, Sansonetti PJ. J Immunol; 2002 May 15; 168(10):5240-51. PubMed ID: 11994481 [Abstract] [Full Text] [Related]
6. Molecular and cellular mechanisms of invasion of the intestinal barrier by enteric pathogens. The paradigm of Shigella. Sansonetti PJ. Folia Microbiol (Praha); 1998 May 15; 43(3):239-46. PubMed ID: 9717250 [Abstract] [Full Text] [Related]
9. Shigella flexneri Interactions with the Basolateral Membrane Domain of Polarized Model Intestinal Epithelium: Role of Lipopolysaccharide in Cell Invasion and in Activation of the Mitogen-Activated Protein Kinase ERK. Köhler H, Rodrigues SP, McCormick BA. Infect Immun; 2002 Mar 25; 70(3):1150-8. PubMed ID: 11854195 [Abstract] [Full Text] [Related]
10. Sumoylation controls host anti-bacterial response to the gut invasive pathogen Shigella flexneri. Fritah S, Lhocine N, Golebiowski F, Mounier J, Andrieux A, Jouvion G, Hay RT, Sansonetti P, Dejean A. EMBO Rep; 2014 Sep 25; 15(9):965-72. PubMed ID: 25097252 [Abstract] [Full Text] [Related]
13. Tyrosine kinases, drugs, and Shigella flexneri dissemination. Dragoi AM, Agaisse H. Gut Microbes; 2014 Sep 25; 5(1):44-7. PubMed ID: 24637806 [Abstract] [Full Text] [Related]
14. Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release. Fiorentino M, Levine MM, Sztein MB, Fasano A. PLoS One; 2014 Sep 25; 9(1):e85211. PubMed ID: 24416363 [Abstract] [Full Text] [Related]
15. Molecular bases of epithelial cell invasion by Shigella flexneri. Sansonetti PJ, Egile C. Antonie Van Leeuwenhoek; 1998 Nov 25; 74(4):191-7. PubMed ID: 10081579 [Abstract] [Full Text] [Related]
16. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Mumy KL, Chen X, Kelly CP, McCormick BA. Am J Physiol Gastrointest Liver Physiol; 2008 Mar 25; 294(3):G599-609. PubMed ID: 18032477 [Abstract] [Full Text] [Related]
18. Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Mathias A, Longet S, Corthésy B. Infect Immun; 2013 Aug 25; 81(8):3027-34. PubMed ID: 23753631 [Abstract] [Full Text] [Related]
19. [In vitro model for the analysis of the interaction between Shigella flexneri and the intestinal epithelium]. Raygoza-Anaya M, González-Robles A, Mora-Galindo J. Arch Invest Med (Mex); 1990 Aug 25; 21(4):305-9. PubMed ID: 1669218 [Abstract] [Full Text] [Related]